Vidac Pharma publishes results of next-generation drug candidate tests in human and murine tumor models
25 juil. 2024 01h30 HE
|
Vidac Pharma Holding PLC
London (UK), July 25, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel...